Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30877086 | 0.84 | SMN1; SMN2 (0.46) | — | |
| SCHEMBL30877085 | 0.84 | SMN1; SMN2 (0.46) | — | |
| Lithium Ion SCHEMBL29030328 | 0.80 | THRB (0.37) | ALDH1A1TSHR | |
| SCHEMBL2809651 | 0.76 | TSHR (0.33) | TSHR | |
| SCHEMBL28590726 | 0.72 | THRB (0.36) | ALDH1A1TSHR | |
| SCHEMBL27751323 | 0.72 | ADRA1D (0.32) | — | |
| SCHEMBL4937680 | 0.70 | TSHR (0.39) | ALDH1A1TSHR | |
| SCHEMBL28151167 | 0.70 | CHRM5 (0.38) | TSHR | |
| SCHEMBL3683081 | 0.70 | SMN1; SMN2 (0.47) | ALDH1A1 | |
| SCHEMBL3411389 | 0.68 | ALDH1A1 (0.46) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2776446-B1 | POLYMERISABLE MATERIAL | VERTELLUS SPECIALTIES INC (US) | 2016-10-05 | — | — | EP | disclosed |
| US-8980956-B2 | Methods for producing biocompatible materials | VERTELLUS SPECIALITIES INC. (US) | 2015-03-17 | — | — | US | disclosed |
| US-8980972-B2 | Polymerisable material | VERTELLUS SPECIALTIES INC. (US) | 2015-03-17 | — | — | US | disclosed |
| EP-2776446-A1 | POLYMERISABLE MATERIAL | Vertellus Specialties Inc. (US) | 2014-09-17 | — | — | EP | disclosed |
| EP-2751153-A1 | METHODS FOR PRODUCING BIOCOMPATIBLE MATERIALS | Vertellus Specialties Inc. (US) | 2014-07-09 | — | — | EP | disclosed |
| US-20130120708-A1 | POLYMERISABLE MATERIAL | VERTELLUS HOLDINGS, LLC | 2013-05-16 | — | — | US | disclosed |
| WO-2013070306-A1 | POLYMERISABLE MATERIAL | VERTELLUS SPECIALTIES INC. (US) | 2013-05-16 | — | — | WO | disclosed |
| US-20130059926-A1 | METHODS FOR PRODUCING BIOCOMPATIBLE MATERIALS | VERTELLUS HOLDINGS, LLC | 2013-03-07 | — | — | US | disclosed |
| WO-2013033553-A1 | METHODS FOR PRODUCING BIOCOMPATIBLE MATERIALS | VERTELLUS SPECIALTIES INC. (US) | 2013-03-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130120708-A1 | POLYMERISABLE MATERIAL | VCL, ZW10, PARG | ALDH1A1 4687/4885TSHR 4782/4885 |
| US-20130059926-A1 | METHODS FOR PRODUCING BIOCOMPATIBLE MATERIALS | VCL, ECPAS, MACF1 | ALDH1A1 2708/4885TSHR 4832/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.